Related Experiment Video
Updated: May 16, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Diagnosis and treatment of enthesitis-related arthritis
1Division of Rheumatology and Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Departments of Pediatrics and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Insights
Juvenile idiopathic arthritis (JIA) includes enthesitis-related arthritis (ERA), a condition affecting 10-20% of children. ERA management involves NSAIDs, DMARDs, and biologics, often adapted from adult RA and AS treatments.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Inflammatory Diseases
Background:
- Juvenile idiopathic arthritis (JIA) is a chronic inflammatory condition of unknown cause.
- Enthesitis-related arthritis (ERA) is a JIA subtype encompassing diverse presentations like enthesitis, arthritis, juvenile ankylosing spondylitis, and IBD-associated arthropathy.
- ERA represents 10-20% of all JIA cases.
Purpose of the Study:
- To describe the clinical characteristics and common manifestations of ERA in children.
- To outline current treatment strategies for ERA.
- To highlight the heterogeneity within the ERA JIA category.
Main Methods:
- Literature review of JIA and ERA.
- Analysis of clinical manifestations in ERA patients.
- Summary of established treatment protocols for ERA.
Main Results:
- ERA commonly presents with arthritis, enthesitis, and acute anterior uveitis.
- Axial disease is frequently observed in children with established ERA.
- Treatment approaches include NSAIDs, DMARDs, and biologics, often drawing from adult RA and AS protocols.
Conclusions:
- ERA is a significant subtype of JIA with varied clinical features and a notable prevalence of axial disease.
- Current treatment strategies for ERA are adapted from adult rheumatologic conditions.
- Further research may refine ERA-specific treatment guidelines.
Abstract:
Juvenile idiopathic arthritis (JIA) is a chronic, inflammatory disease of unknown etiology. The enthesitis-related arthritis (ERA) JIA category describes a clinically heterogeneous group of children including some who have predominately enthesitis, enthesitis and arthritis, juvenile ankylosing spondylitis, or inflammatory bowel disease-associated arthropathy. ERA accounts for 10%-20% of JIA. Common clinical manifestations of ERA include arthritis, enthesitis, and acute anterior uveitis. Axial disease is also common in children with established ERA. Treatment regimens for ERA, many of them based on adults with rheumatoid arthritis and ankylosing spondylitis, include the use of nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, and biologic agents either individually or in combination.
Related Concept Videos
Endocarditis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Rheumatic Heart Disease III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests